参考文献/References:
[1].McKenney-Drake ML,Moghbel MC,Paydary K,et al. 18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis[J]. Eur J Nucl Med Mol Imaging,2018,45(12):2190-2200.
[2].Kloner RA. Stunned and hibernating myocardium:where are we nearly 4 decades later?[J]. J Am Heart Assoc,2020,9(3):e015502.
[3].Andrews JPM,Fayad ZA,Dweck MR. New methods to image unstable atherosclerotic plaques[J]. Atherosclerosis,2018,272:118-128.
[4].Davidson CQ,Phenix CP,Tai TC,et al. Searching for novel PET radiotracers:imaging cardiac perfusion,metabolism and inflammation[J]. Am J Nucl Med Mol Imaging,2018,8(3):200-227.
[5].Yap ML,Peter K. Molecular positron emission tomography in cardiac ischemia/reperfusion[J]. Circ Res,2019,124(6):827-829.
[6].Jamiel A,Ebid M,Ahmed AM,et al. The role of myocardial viability in contemporary cardiac practice[J]. Heart Fail Rev,2017,22(4):401-413.
[7].Koelwyn GJ,Corr EM,Erbay E,et al. Regulation of macrophage immunometabolism in atherosclerosis[J]. Nat Immunol,2018,19(6):526-537.
[8].Barrett TJ. Macrophages in atherosclerosis regression[J]. Arterioscler Thromb Vasc Biol,2020,40(1):20-33.
[9].Joseph P,Tawakol A. Imaging atherosclerosis with positron emission tomography[J]. Eur Heart J,2016,37(39):2974-2980.
[10].MacAskill MG,Newby DE,Tavares AAS. Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque[J].?Cardiovasc Res,2019,115(14):1952-1962.
[11].Tarkin JM,Joshi FR,Evans NR,et al. Detection of atherosclerotic inflammation by 68Ga-DOTATATE PET compared to [18F]FDG PET imaging[J]. J Am Coll Cardiol,2017,69(14):1774-1791.
[12].Irkle A,Vesey AT,Lewis DY,et al. Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography[J]. Nat Commun,2015,6:7495.
[13].Tzolos E,Dweck MR. 18F-Sodium Fluoride(18F-NaF) for imaging microcalcification activity in the cardiovascular system[J]. Arterioscler Thromb Vasc Biol,2020,40(7):1620-1626.
[14].Bing R,Loganath K,Adamson P,et al. Non-invasive imaging of high-risk coronary plaque:the role of computed tomography and positron emission tomography[J]. Br J Radiol,2020,93(1113):20190740.
[15].Strauss HW,Nakahara T,Narula N,et al. Vascular calcification:the evolving relationship of vascular calcification to major acute coronary events[J]. J Nucl Med,2019,60(9):1207-1212.
[16].Moss AJ,Doris MK,Andrews JPM,et al. Molecular coronary plaque imaging using18F-fluoride[J]. Circ Cardiovasc Imaging,2019,12(8):e00857.
[17].Yonetsu T,Jang IK. Advances in intravascular imaging:new insights into the vulnerable plaque from imaging studies[J]. Korean Circ J,2018, 48(1):1-15.
[18].Kavurma MM,Rayner KJ,Karunakaran D. The walking dead:macrophage inflammation and death in atherosclerosis[J]. Curr Opin Lipidol,2017,28(2):91-98.
[19].Iwatsuka R,Matsue Y,Yonetsu T,et al. Arterial inflammation measured by 18F-FDG-PET-CT to predict coronary events in older subjects[J]. Atherosclerosis,2018,268:49-54.
[20].Hetterich H,Rominger A,Walter L,et al. Natural history of atherosclerotic disease progression as assessed by 18F-FDG PET/CT[J]. Int J Cardiovasc Imaging,2016,32(1):49-59.
[21].Nakahara T,Dweck MR,Narula N. Coronary artery calcification:from mechanism to molecular imaging[J]. JACC Cardiovasc Imaging,2017,10(5):582-593.
[22].Greenland P,Blaha MJ,Budoff MJ,et al. Coronary calcium score and cardiovascular risk[J].?J Am Coll Cardiol,2018,72(4):434-447.
[23].Strauss HW,Nakahara T,Narula N,et al. Vascular calcification:the evolving relationship of vascular calcification to major acute coronary events[J]. J Nucl Med,2019,60(9):1207-1212.
[24].Wang X,Matsumura M,Mintz GS,et al. In vivo calcium detection by comparing optical coherence tomography,intravascular ultrasound,and angiography[J]. JACC Cardiovasc Imaging,2017,10(8):869-879.
[25].H?ilund-Carlsen PF,Sturek M,Alavi A,et al. Atherosclerosis imaging with 18F-sodium fluoride PET:state-of-the-art review[J]. Eur J Nucl Med Mol Imaging,2020,47(6):1538-1551.
[26].Kwiecinski J,Tzolos E,Adamson PD,et al. Coronary18F-sodium fluoride uptake predicts outcomes in patients with coronary artery disease[J].?J Am Coll Cardiol,2020,75(24):3061-3074.
[27].Blomberg BA,Thomassen A,de Jong PA,et al. Coronary fluorine-18-sodium fluoride uptake is increased in healthy adults with an unfavorable cardiovascular risk profile:results from the CAMONA study[J]. Nucl Med Commun,2017,38(11):1007-1014.
[28].Kazakauskait? E, ?aliaduonyt?-Pek?ien? D, Rumbinait? E,et al. Positron emission tomography in the diagnosis and management of coronary artery disease[J]. Medicina (Kaunas),2018,54(3) :47.
[29].Tantawy HM,Abdelhafez YG,Helal NL,et al. Variation of contrast values for myocardial perfusion imaging in single-photon emission computed tomography/computed tomography hybrid systems with different correction methods[J].?J Clin Imaging Sci,2020,10:58.
[30].Danad I,Raijmakers PG,Driessen RS,et al. Comparison of coronary CT angiography,SPECT,PET,and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve[J].?JAMA Cardiol,2017,2(10):1100-1107.
[31].Lau JMC,Raptis DA,Laforest R,et al. Cardiac positron emission tomography-magnetic resonance imaging:current status and future directions[J]. J Thorac Imaging,2018,33(3):139-146.
[32].Khalaf S,Chamsi-Pasha M,Al-Mallah MH. Assessment of myocardial viability by PET[J].?Curr Opin Cardiol,2019,34(5):466-472.
相似文献/References:
[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(9):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients
with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(9):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for
Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(9):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[4]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(9):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[5]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(9):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[6]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by
Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(9):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[7]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(9):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[8]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(9):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[9]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(9):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[10]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(9):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]